共 271 条
[1]
Hundahl SA(1998)A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns] Cancer 83 2638-2648
[2]
Fleming ID(2015)Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma Thyroid : official journal of the American Thyroid Association 25 567-610
[3]
Fremgen AM(2013)Cabozantinib in progressive medullary thyroid cancer J Clin Oncol 31 3639-3646
[4]
Menck HR(2012)Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial J Clin Oncol 30 134-141
[5]
Wells SA(2001)Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy Virchows Arch 439 787-797
[6]
Asa SL(2001)Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt J Clin Endocrinol Metab 86 2161-2169
[7]
Dralle H(1991)Somatostatin receptors and somatostatin content in medullary thyroid carcinomas Lab Investig 64 567-573
[8]
Elisei R(2016)Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis APMIS 124 839-845
[9]
Evans DB(1995)Somatostatin receptor imaging in persistent medullary thyroid carcinoma Clin Endocrinol 42 31-37
[10]
Gagel RF(1993)In vivo somatostatin receptor imaging in medullary thyroid carcinoma J Clin Endocrinol Metab 76 1413-1417